Latest News about NVO
Recent news which mentions NVO
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
February 02, 2025
Tickers
NVO
From Motley Fool
Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
February 01, 2025
From Motley Fool
From Motley Fool
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
January 29, 2025
From Benzinga
5 Monster Stocks to Hold for the Next 10 Years
January 29, 2025
From Motley Fool
Ozempic Receives FDA Approval To Treat Kidney Disease
January 28, 2025
From Benzinga
How Ozempic And Legal Weed Are Changing What America Eats
January 28, 2025
From Benzinga
From Benzinga
Why Eli Lilly Stock Topped the Market Today
January 24, 2025
From Motley Fool
Stocks Stall, Gold Nears Record Highs As Dollar Faces Worst Week Since July 2023: What's Driving Markets Friday?
January 24, 2025
From Benzinga
Why Novo Nordisk Stock Jumped a Lucky 7.7% Today
January 24, 2025
From Motley Fool
From Benzinga
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
January 24, 2025
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
January 21, 2025
Tickers
NVO
From Benzinga
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
January 21, 2025
Tickers
NVO
From Motley Fool
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
From Benzinga
Is Novo Nordisk Stock a Buy?
January 18, 2025
From Motley Fool
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
January 17, 2025
From Motley Fool
5 Stocks to Buy Now for Big Returns in 2025
January 17, 2025
From Motley Fool
Novo Nordisk's Higher Dose Of Wegovy Shows Roughly 21% Weight Loss
January 17, 2025
From Benzinga
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
January 17, 2025
From Motley Fool
Stocks Fail To Rise Despite Benign Producer Inflation, 30-Year Treasury Yields Hit 5%, Ely Lilly Tumbles: What's Driving Markets Tuesday?
January 14, 2025
From Benzinga
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.